Kristen N. Ganjoo

Stanford University School of MedicineStanford, California - 94305 Stanford UniversityPalo Alto, California - 94304 (650-723-5711) |
- CLINICAL TRIALS 6
- CONDITIONS16
- INTERVENTIONS15
- SINCE2001

Study of Bexxar Combined With External Beam Radiation Therapy for Patients With Relapsed Bulky Non-Hodgkin's Lymphoma
January 2007 - December 2015

Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
February 2009 - August 2010

Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma
August 2008 - August 2010

Paclitaxel + Bevacizumab (Avastin ) for the Treatment of Metastatic or Unresectable Angiosarcoma
February 2010 - December 2011

Trial of Dasatinib in Advanced Sarcomas
May 2007 - December 2013

Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
June 2001 - June 2012
Lymphoma
Lymphoma, Non-Hodgkin
Bone Neoplasms
Hemangiopericytoma
Hodgkin Disease
Sarcoma
Gastrointestinal Stromal Tumors
Giant Cell Tumors
Rhabdomyosarcoma
Chordoma
Nerve Sheath Neoplasms
Chondrosarcoma
Hemangiosarcoma
Giant Cell Tumor of Bone
Sarcoma, Alveolar Soft Part
Sarcoma, Ewing's
Tositumomab And Iodine I 131 Tositumomab
External Beam Radiotherapy
Rituximab
Dasatinib
Cyclophosphamide
Prednisone
Radiation Therapy
Doxorubicin Hydrochloride
Etoposide
Vincristine
Bleomycin
Vinblastine
Chemotherapy
Th-302
Paclitaxel In Combination With Bevacizumab



